Olympus Corporation (OTCPK:OLYMY) Q1 2026 Earnings Conference Call August 8, 2025 2:00 AM ET
Company Participants
Bob White – Director, Representative Executive Officer, President and Chief Executive Officer
Boris Shkolnik – Executive Officer and Chief Quality Officer
Frank Drewalowski – Executive Officer of Gastrointestinal Solutions
Seiji Kuramoto – Executive Officer and Surgical and Interventional Solutions
Tatsuya Izumi – Executive Officer and Chief Financial Officer
Conference Call Participants
Bob White
Hello, everyone. Thank you for joining us today for our FY2026 Q1 earnings call.
My name is Bob White, President and CEO of Olympus. As many of you know, I was appointed as CEO in June, and it’s an honor to address you for the first time as CEO of Olympus. I would like to start by expressing my gratitude to our employees, customers and stakeholders for their continued trust and support during this period of transition.
That said, I want to share my candid views on our Q1 performance, which fell short of expectations.
In the Q1, consolidated revenues decreased by 12% YoY to JPY206.5 billion. Furthermore, insufficient short-term cost control in the face of revenue declines resulted in a drop in adjusted operating profit to JPY13.2 billion. Major markets, excluding APAC, experienced challenging results.
In particular, the US faced challenges due to difficult comparison to prior year’s strong performance, which was driven by the launch of EVIS X1 and the elimination of back orders following the Noto earthquake. Then, in Q1 of this year, we experienced a delay in purchases ahead of the upcoming new product launches in this fiscal year.
In Japan, the challenging environment surrounding hospital management persists. While in China, the business climate is affected by the ongoing impact of the Buy China policy.
Regarding the revenue forecast for the balance of this fiscal year, we do
#Olympus #Corporation #OLYMY #Earnings #Call #Transcript